Search research articles
Contact Us
Filters
Showing results (81-90 of 84) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 84 results.
Stem Cells Translational Medicine
|
May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction
Angela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Journal of the American College of Cardiology
|
November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration
Makoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
Circulation Research
|
September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)
Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Journal of the American College of Cardiology
|
November 19, 2016
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial
Joshua M Hare, Darcy L DiFede, Angela C Rieger, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 84) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 84 results.
Stem Cells Translational Medicine
|
May 31, 2022
Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction
Angela C Rieger, Bryon A Tompkins, Makoto Natsumeda, et al.
Journal of the American College of Cardiology
|
November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration
Makoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
Circulation Research
|
September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)
Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Journal of the American College of Cardiology
|
November 19, 2016
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial
Joshua M Hare, Darcy L DiFede, Angela C Rieger, et al.
Page
of 9